Indian pharma market crosses Rs 1,00,000 crore mark: IMS Health  MUMBAI: The Indian pharmaceutical market has for the first time crossed the Rs 100000 crore mark in November when calculated on the basis of Moving Annual Total (MAT), said IMS Health, a global pharmaceutical market research firm. In its monthly review of the local market, IMS Health said in its ... Read More »

FDA approves Wellstat’s Vistogard for chemotherapy overdose The US Food and Drug Administration (FDA) has approved Wellstat Therapeutics’ Vistogard (uridine triacetate) to treat overdose of fluorouracil or capecitabine, which are administered for several malignancies. Vistogard is claimed to be the first antidote for emergency treatment of 5-fluorouracil (5-FU) overdose treatment available to patients. It is also indicated for patients exhibiting ... Read More »

                       The Stone Cutter   Once upon a time there lived a stone cutter ,in a small village. All day long he worked hard, cutting the hard stones and making the shape which were needed by his customers. His hands were hard and his clothes were dirty. One day he ... Read More »

Bial’s Zebinix meets primary endpoint in phase 3 study for patients with newly diagnosed partial-onset seizures Bial has unveiled positive results for a pivotal phase 3 non-inferiority study comparing the efficacy and safety of eslicarbazepine acetate (ESL) to controlled release carbamazepine (CBZ-CR) as monotherapy in newly diagnosed adult patients with partial-onset seizures (POS). Bial director of research & development department ... Read More »

Can Pfizer finally orchestrate a winning megamerger after so many disappointments? Pfizer’s ($PFE) decision to buy Allergan ($AGN) wasn’t much of a surprise; the nominally Dublin-based Allergan was among the few buyout targets that could deliver CEO Ian Read‘s desired tax inversion. Nor is it surprising that Pfizer chose to rack up another megamerger, given its history of huge deals. ... Read More »

Heptares Therapeutics, Pfizer partner for GPCR-focused drug discovery Heptares Therapeutics and Pfizer have signed a drug discovery collaboration agreement, focused on G protein-coupled receptor (GPCR) targets across several therapeutic areas. Under the collaboration, the companies will research and develop potential new medicines directed at about 10 GPCR targets. Heptares will apply its GPCR structure-guided platform to help offer stabilized GPCRs ... Read More »

Mega Merger: Pfizer and Allergan to combine Pfizer and Allergan to merge in a $160 billion deal Pfizer and Allergan has announced that their boards of directors have unanimously approved, and the companies have entered into, a definitive merger agreement under which Pfizer will combine with Allergan in a stock transaction currently valued at $363.63 per Allergan share, for a ... Read More »

Dr Reddy’s barred from selling Esomeprazole Capsules in the US : Dr Reddy’s has received a Temporary Restraining Order (TRO) for Esomeprazole Capsules . The District Court of Delaware, USA, has passed an order granting a Temporary Restraining Order (TRO) with immediate effect on sales, delivery, transfer, or other disposition of Dr Reddy’s Laboratories’ generic esomeprazole product in the US ... Read More »

Laughter is The Best Medicine Many years ago, Norman Cousins was diagnosed as “terminally ill”. He was given six months to live. His chance for recovery was 1 in 500. He could see the worry, depression and anger in his life contributed to, and perhaps helped cause, his disease. He wondered, “If illness can be caused by negativity, can wellness ... Read More »

Arogya Finance and DRL collaborate to provide medical loans for financially weak Facilitates medical loans for Resof, a drug for treatment of Hepatitis C virus (HCV) infection and a few other therapies Arogya Finance has tied up with Dr Reddy’s Laboratories for providing medical loans for treatment of Hepatitis C. Reportedly, Arogya Finance will facilitate easy Equated Monthly Installments to patients ... Read More »